FDA MedWatch Recall Notice - Related to Valsartan and Valsartan Hydrochlorothiazide Tablets

Recall posted on July 17, 2018:

• Valsartan and valsartan hydrochlorothiazide) tablets by Teva Pharmaceuticals USA - recall due to impurity detected in the API is N-nitrosodimethylamine

Recall posted on July 13, 2018:

• Valsartan and Valsartan-Hydrochlorothiazide tablets by Prinston Pharmaceutical - recall due to detection of a trace amount of unexpected impurity, N-nitrosodimethylamine (NDMA)
• Valsartan tablets by Major Pharmaceuticals - recall due to probable carcinogen N-nitrosodimethylamine (NDMA)